Matthew P. Ottmer

53 year

Health Technology

Consumer Services

Profile

Matthew P.
Ottmer worked as Senior VP-Strategy & Emerging Businesses at Biogen, Inc. from 2014 to 2015, followed by a position as Chief Operating Officer at Momenta Pharmaceuticals, Inc. from 2015 to 2017.
He then became President at Bioverativ Therapeutics, Inc. before serving as Chief Operating Officer at Voyager Therapeutics, Inc. from 2017 to 2020.
Ottmer received his undergraduate degree from the University of Michigan and his MBA from Kellogg School of Management.

Former positions of Matthew P. Ottmer

Companies	Position	End
VOYAGER THERAPEUTICS, INC.	Chief Operating Officer	2020-02-11
MOMENTA PHARMACEUTICALS, INC.	Chief Operating Officer	2017-03-31
BIOGEN INC.	Corporate Officer/Principal	2015-06-30
Bioverativ Therapeutics, Inc. Bioverativ Therapeutics, Inc. Pharmaceuticals: MajorHealth Technology Bioverativ Therapeutics, Inc. develops pharmaceutical products. It develops medicines for chronic diseases such as hemophilia, anemia, multiple sclerosis, and autoimmune disorders. The company is headquartered in Cambridge, MA.	President	-

See the detail of Matthew P. Ottmer's experience

Training of Matthew P. Ottmer

University of Michigan	Undergraduate Degree
Kellogg School of Management	Masters Business Admin

Experiences
Positions held

Active

Inactive

Listed companies

Private companies

See the detail of Matthew P. Ottmer's experience

Connections

100 +

1st degree connections

1st degree companies

Male

Female

Members of the board

Executives

See the personal network

Linked companies

Listed companies	2
BIOGEN INC.	Health Technology
VOYAGER THERAPEUTICS, INC.	Health Technology

Private companies	2
Momenta Pharmaceuticals, Inc. Momenta Pharmaceuticals, Inc. Pharmaceuticals: MajorHealth Technology Momenta Pharmaceuticals, Inc. operates as a biotechnology company that focuses on the discovery and development of novel biologic therapies for the treatment of rare immune-mediated diseases. Its products include the Glatiramer acetate injection and Enoxaparin Sodium injection. The company was founded by Ram Sasisekharan, Paul R. Schimmel, and Ganesh Venkatraman Kaundinya in May 2001 and is headquartered in Cambridge, MA.	Health Technology
Bioverativ Therapeutics, Inc. Bioverativ Therapeutics, Inc. Pharmaceuticals: MajorHealth Technology Bioverativ Therapeutics, Inc. develops pharmaceutical products. It develops medicines for chronic diseases such as hemophilia, anemia, multiple sclerosis, and autoimmune disorders. The company is headquartered in Cambridge, MA.	Health Technology